Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase.
Chris J. Vlahos(Eli Lilly (United States)), William F. Matter(Eli Lilly (United States)), Alexis Traynor‐Kaplan(Eli Lilly (United States)), Philip Marder(Eli Lilly (United States)), Raymond F. Brown(Eli Lilly (United States)), Kimberly J. Rothfuss(Eli Lilly (United States)), Eric R. Prossnitz(UNM Comprehensive Cancer Center), J A Schelm(Eli Lilly (United States)), R D Ye(Scripps Research Institute), P G Heyworth(University of Iowa)
Cited by 174
Related Papers
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
|Journal of Biological Chemistry|1994|3.3k
Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.
|Journal of Clinical Investigation|1991|372
The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs
|Biochemical and Biophysical Research Communications|1992|198
G Protein-coupled Estrogen Receptor Protects from Atherosclerosis
|Scientific Reports|2014|149
Antagonists of Phosphatidylinositol 3-Kinase Block Activation of Several Novel Protein Kinases in Neutrophils
|Journal of Biological Chemistry|1995|125